Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Anaemia to predict radiographic progression in rheumatoid arthritis.

van Steenbergen HW, van Nies JA, van der Helm-van Mil AH.

Ann Rheum Dis. 2013 Jul;72(7):e16. doi: 10.1136/annrheumdis-2013-203718. Epub 2013 Apr 26. No abstract available.

PMID:
23625976
2.

Anaemia may add information to standardised disease activity assessment to predict radiographic damage in rheumatoid arthritis: a prospective cohort study.

Möller B, Scherer A, Förger F, Villiger PM, Finckh A; Swiss Clinical Quality Management Program for Rheumatic Diseases.

Ann Rheum Dis. 2014 Apr;73(4):691-6. doi: 10.1136/annrheumdis-2012-202709. Epub 2013 Mar 16.

3.

Radiographic progression is getting milder in patients with early rheumatoid arthritis. Results of 3 cohorts over 5 years.

Sokka T, Kautiainen H, Häkkinen A, Hannonen P.

J Rheumatol. 2004 Jun;31(6):1073-82.

PMID:
15170917
4.

Implementation of a treat-to-target strategy in very early rheumatoid arthritis: results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort study.

Vermeer M, Kuper HH, Hoekstra M, Haagsma CJ, Posthumus MD, Brus HL, van Riel PL, van de Laar MA.

Arthritis Rheum. 2011 Oct;63(10):2865-72. doi: 10.1002/art.30494.

6.

Rheumatoid arthritis near remission: clinical rather than laboratory inflammation is associated with radiographic progression.

Aletaha D, Alasti F, Smolen JS.

Ann Rheum Dis. 2011 Nov;70(11):1975-80. doi: 10.1136/ard.2011.153734. Epub 2011 Jul 28.

PMID:
21803751
7.
8.

Efficacy of initial methotrexate monotherapy versus combination therapy with a biological agent in early rheumatoid arthritis: a meta-analysis of clinical and radiographic remission.

Kuriya B, Arkema EV, Bykerk VP, Keystone EC.

Ann Rheum Dis. 2010 Jul;69(7):1298-304. doi: 10.1136/ard.2009.118307. Epub 2010 Apr 26. Review.

PMID:
20421343
9.

The effectiveness of leflunomide as a co-therapy of tumour necrosis factor inhibitors in rheumatoid arthritis: a population-based study.

Finckh A, Dehler S, Gabay C; SCQM doctors.

Ann Rheum Dis. 2009 Jan;68(1):33-9. doi: 10.1136/ard.2007.085696. Epub 2008 Jan 29.

PMID:
18230627
10.

Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis.

van der Heijde D, Klareskog L, Landewé R, Bruyn GA, Cantagrel A, Durez P, Herrero-Beaumont G, Molad Y, Codreanu C, Valentini G, Zahora R, Pedersen R, MacPeek D, Wajdula J, Fatenejad S.

Arthritis Rheum. 2007 Dec;56(12):3928-39.

11.

Disease activity score-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis: data from the GUEPARD trial and ESPOIR cohort.

Soubrier M, Lukas C, Sibilia J, Fautrel B, Roux F, Gossec L, Patternotte S, Dougados M.

Ann Rheum Dis. 2011 Apr;70(4):611-5. doi: 10.1136/ard.2010.137695. Epub 2011 Jan 17.

12.

Evaluation of the preliminary definitions of minimal disease activity and remission in an early seropositive rheumatoid arthritis cohort.

Khanna D, Oh M, Furst DE, Ranganath V, Gold RH, Sharp JT, Park GS, Keystone EC, Paulus HE; Western Consortium of Practicing Rheumatologists.

Arthritis Rheum. 2007 Apr 15;57(3):440-7.

13.

Factors associated with radiographic progression in patients with rheumatoid arthritis who were treated with methotrexate.

Weinblatt ME, Keystone EC, Cohen MD, Freundlich B, Li J, Chon Y, Baumgartner SW.

J Rheumatol. 2011 Feb;38(2):242-6. doi: 10.3899/jrheum.091446. Epub 2010 Nov 15.

PMID:
21078715
14.

Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression.

Brown AK, Quinn MA, Karim Z, Conaghan PG, Peterfy CG, Hensor E, Wakefield RJ, O'Connor PJ, Emery P.

Arthritis Rheum. 2006 Dec;54(12):3761-73.

15.

The impact of four dynamic, goal-steered treatment strategies on the 5-year outcomes of rheumatoid arthritis patients in the BeSt study.

Klarenbeek NB, Güler-Yüksel M, van der Kooij SM, Han KH, Ronday HK, Kerstens PJ, Seys PE, Huizinga TW, Dijkmans BA, Allaart CF.

Ann Rheum Dis. 2011 Jun;70(6):1039-46. doi: 10.1136/ard.2010.141234. Epub 2011 Mar 17.

PMID:
21415052
16.

Superiority of SDAI over DAS-28 in assessment of remission in rheumatoid arthritis patients using power Doppler ultrasonography as a gold standard.

Balsa A, de Miguel E, Castillo C, Peiteado D, Martín-Mola E.

Rheumatology (Oxford). 2010 Apr;49(4):683-90. doi: 10.1093/rheumatology/kep442. Epub 2010 Jan 4.

17.

An evaluation of molecular and clinical remission in rheumatoid arthritis by assessing radiographic progression.

van der Helm-van Mil AH, Knevel R, Cavet G, Huizinga TW, Haney DJ.

Rheumatology (Oxford). 2013 May;52(5):839-46. doi: 10.1093/rheumatology/kes378. Epub 2013 Jan 3.

18.

Rheumatoid arthritis: radiographic progression is getting milder.

Krishnan E, Fries JF.

J Rheumatol. 2005 Jan;32(1):195; author reply 195. No abstract available.

19.

The long-term impact of early treatment of rheumatoid arthritis on radiographic progression: a population-based cohort study.

Kyburz D, Gabay C, Michel BA, Finckh A; physicians of SCQM-RA.

Rheumatology (Oxford). 2011 Jun;50(6):1106-10. doi: 10.1093/rheumatology/keq424. Epub 2011 Jan 21.

20.

Misclassification of disease activity when assessing individual patients with early rheumatoid arthritis using disease activity indices that do not include joints of feet.

Bakker MF, Jacobs JW, Kruize AA, van der Veen MJ, van Booma-Frankfort C, Vreugdenhil SA, Bijlsma JW, Lafeber FP, Welsing PM.

Ann Rheum Dis. 2012 Jun;71(6):830-5. doi: 10.1136/annrheumdis-2011-146670. Epub 2011 Nov 29.

PMID:
22128075
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk